Systemic Lupus Erythematosus Market accounted for US$ 1.87 billion in 2019 and is estimated to be US$ 3.6 billion by 2029
The report "Systemic Lupus Erythematosus Market, By Drug Classes (NSAIDs, Corticosteroids, Antimalarials, Immunosuppressants, and Biologics), By Route of Administration (Oral, Intravenous, and Subcutaneous), and By Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Trends, Analysis and Forecast till 2029”. According to National Institute of Arthritis and Musculoskeletal and Skin Diseases, the occerence of this disease is highly in the African-American and Asian populations. Women from the Asian, Afro-Caribbean and Hispanic descent are primarily affected by this disease. Over the past few decades, the global SLE drugs market has observed a paradigm shift from generic and off label drugs to advanced innovator drugs with improved delivery options. Previously, the market was fortified with multiple drugs administered through conventional routes such as oral, intravenous and topical formulations.
Key Market Insights from the report:
The global systemic lupus erythematosus market accounted for US$ 1.87 billion in 2019 and is estimated to be US$ 3.6 billion by 2029 and is anticipated to register a CAGR of 7.0%. The market report has been segmented on the basis of drug classes, route of administration, and region.
By drug classes, immunosuppressants held the dominating revenue share in the global market in 2019, owing to adoption of methotrexate across the globe, which is accessible at low cost. Biologics accounted for the second-highest after the segment due to the slow penetration of Benlysta.
By region, North America lead the global market in 2019, with the U.S. at the leading position. The region is expected to maintain its dominance over the forecast period. Higher prevalence of SLE along with coverage for specialty drugs and improved healthcare infrastructure is driving to the growth of the regional market.
Before purchasing this report, request a sample or make an inquiry by clicking the following link:
https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/4418
Competitive Landscape:
The prominent player operating in the global systemic lupus erythematosus market includes GlaxoSmithKline, Novartis, Roche, Bayer, Pfizer, Sanofi, F. Hoffmann-la Roche Ltd., Hadasit Medical Research Services and Development, Hansa Medical Lab, and Harbor Biosciences.
Related Topics:
https://praticoles.blogspot.com/2022/09/frozen-dessert-market-worth-us-17642.html
https://www.reddit.com/r/unitedstatesofindia/comments/xkunqp/membrane_chromatography_market_analysis_and/
https://praticoles.blogspot.com/2022/09/membrane-chromatography-market-analysis.html
Leave a Comment:
To notify a previous commenter, mention their user name: @peter or @peter-smith if there are spaces.
